SCHEMBL3869346

SCHEMBL3869346

CC(C)(C(N)=O)c1ncccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 1/20 0.43
TRPV1 Q8NER1 2/20 0.40
MKNK1 Q9BUB5 3/20 0.37
MKNK2 Q9HBH9 3/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 2/20 0.35
MITF O75030 1/20 0.35
PKM P14618 1/20 0.35
AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365596 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2ATRPV1HTTLMNA
SCHEMBL19817326 0.81 SSTR4 (0.45) SMN1; SMN2MAPTKMT2ATRPV1MKNK1
SCHEMBL30486616 0.79 POLB (0.42) SMN1; SMN2KMT2ATRPV1HTTLMNA
SCHEMBL10198453 0.79 POLB (0.42) SMN1; SMN2KMT2ATRPV1HTTLMNA
SCHEMBL18668145 0.76 HSD11B1 (0.39) SMN1; SMN2MAPTKMT2ATRPV1HTT
SCHEMBL29724855 0.76 DPP4 (0.36) SMN1; SMN2KMT2ATRPV1HTTLMNA
SCHEMBL179292 0.75 TRPV1 (0.37) MAPTKMT2ATRPV1LMNAALDH1A1
SCHEMBL21631978 0.74 PTGFR (0.44) SMN1; SMN2KMT2ATRPV1HTTLMNA
SCHEMBL20534571 0.73 PTGFR (0.41) SMN1; SMN2KMT2AHTTLMNAALDH1A1
SCHEMBL5054998 0.73 SMN1; SMN2 (0.39) SMN1; SMN2MAPTKMT2AHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101166722-A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH CORP (US) 2008-04-23 CN claimed
EP-1877377-A2 PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES Wyeth (US) 2008-01-16 EP claimed
WO-2006118955-A2 PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES WYETH (US) 2006-11-09 WO claimed
US-20060247441-A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH (US) 2006-11-02 US claimed
US-7595338-B2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH (US) 2009-09-29 US disclosed
US-7595338-B2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH (US) 2009-09-29 US disclosed
CN-101166722-A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH CORP (US) 2008-04-23 CN disclosed
EP-1877377-A2 PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES Wyeth (US) 2008-01-16 EP disclosed
WO-2006118955-A2 PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES WYETH (US) 2006-11-09 WO disclosed
US-20060247441-A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles WYETH (US) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247441-A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles TPMT, TH, HTR3C SMN1; SMN2 2877/4885MAPT 2031/4885KMT2A 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.